Evidence map›Paper›PMID 40677894›Full record

ArticleFrontiers in human neuroscience2025

OCNDS core features are conserved across variants, with loop-region mutations driving greater symptom burden.

Elena D Bagatelas, Maahin Manzoor Khan, Gabrielle V Rushing

Abstract read
In one paragraph

Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elena D BagatelasDepartment of Neuroscience, Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United States.
Maahin Manzoor KhanCSNK2A1 Foundation, San Francisco, CA, United States.
Gabrielle V RushingCSNK2A1 Foundation, San Francisco, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Okur-Chung Neurodevelopmental Syndrome (OCNDS) is an ultra-rare genetic disorder caused by Methods: We analyzed natural history data from 48 individuals with pathogenic or likely pathogenic Results: All individuals reported speech/language delay, with additional common features including global developmental delay, neurological symptoms, and gastrointestinal issues. Variants in loop regions were associated with significantly younger age at diagnosis and a higher frequency of hypotonia. Mutations in the glycine-rich loop-known to bind both ATP and the regulatory CK2β subunit-were linked to significantly higher symptom burden and more non-seizure neurological symptoms. No significant differences were observed between variant locations for core features such as sleep issues, intellectual disability, or speech delay.. Discussion: Our findings suggest a core OCNDS symptom profile that is conserved across genotypes, with loop-region variants contributing to increased symptom burden. These results reinforce the relevance of conserved functional domains in driving phenotype severity and support the use of mutation location as a potential biomarker to stratify patients for therapeutic prioritization. Further studies incorporating functional assays and larger cohorts are needed to elucidate mechanisms of variant-specific pathogenesis and guide personalized intervention strategies.

Indexed as

CK2CSNK2A1genotype–phenotypemissenseOCNDSOkur-ChungSimons searchlight

Identifiers

PMID40677894
PMCPMC12267189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.